Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Apolipoprotein M Protects Against Lipopolysaccharide-Induced Acute Lung Injury via Sphingosine-1-Phosphate Signaling

Zhu, Bin ; Luo, Guang hua ; Feng, Yue hua ; Yu, Miao mei ; Zhang, Jun ; Wei, Jiang ; Yang, Chun ; Xu, Ning LU and Zhang, Xiao ying (2018) In Inflammation 41(2). p.643-653
Abstract

Abstract: It had been demonstrated that apolipoprotein M (apoM) is an important carrier of sphingosine-1-phosphate (S1P) in blood, and the S1P has critical roles in the pathogenesis of sepsis-induced acute lung injury (ALI). In the present study, we investigated whether apoM has beneficial effects in a mouse model after lipopolysaccharide (LPS)-induced ALI. Forty-eight mice were divided into two groups: male C57BL/6 wild-type (apoM+/+) group (n = 24) and apoM gene-deficient (apoM−/−) group (n = 24) and then randomly subdivided into four subgroups (n = 6 each) according to different intraperitoneal (i.p.) injection: control group, W146 group, LPS group, and LPS + W146 group. Serum levels of interleukin-1 beta... (More)

Abstract: It had been demonstrated that apolipoprotein M (apoM) is an important carrier of sphingosine-1-phosphate (S1P) in blood, and the S1P has critical roles in the pathogenesis of sepsis-induced acute lung injury (ALI). In the present study, we investigated whether apoM has beneficial effects in a mouse model after lipopolysaccharide (LPS)-induced ALI. Forty-eight mice were divided into two groups: male C57BL/6 wild-type (apoM+/+) group (n = 24) and apoM gene-deficient (apoM−/−) group (n = 24) and then randomly subdivided into four subgroups (n = 6 each) according to different intraperitoneal (i.p.) injection: control group, W146 group, LPS group, and LPS + W146 group. Serum levels of interleukin-1 beta (IL-1β) and mRNA levels of IL-1β, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α), lung histology, wet/dry weight ratio, and immunohistochemistry were measured at 3 h after the baseline and compared in each group. Our results clearly demonstrated that IL-1β mRNA levels and other inflammatory biomarkers were significantly increased in the lungs of LPS-induced ALI apoM−/− mice compared to those of the apoM+/+ mice. Moreover, when apoM+/+ mice were treated with W146, a S1P receptor (S1PR1) antagonist, these inflammatory biomarkers could be significantly upregulated by LPS-induced ALI. Therefore, it suggests that apoM-S1P-S1PR1 signaling might underlie the pathogenesis of ALI and apoM could have physiological benefits to alleviate LPS-induced ALI.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Inflammation
volume
41
issue
2
pages
643 - 653
publisher
Springer
external identifiers
  • scopus:85038370633
  • pmid:29260347
ISSN
0360-3997
DOI
10.1007/s10753-017-0719-x
language
English
LU publication?
yes
id
e7d7e85b-36bc-4aa1-b086-9d5a11f62eda
date added to LUP
2018-01-03 12:13:51
date last changed
2024-04-14 22:29:04
@article{e7d7e85b-36bc-4aa1-b086-9d5a11f62eda,
  abstract     = {{<p>Abstract: It had been demonstrated that apolipoprotein M (apoM) is an important carrier of sphingosine-1-phosphate (S1P) in blood, and the S1P has critical roles in the pathogenesis of sepsis-induced acute lung injury (ALI). In the present study, we investigated whether apoM has beneficial effects in a mouse model after lipopolysaccharide (LPS)-induced ALI. Forty-eight mice were divided into two groups: male C57BL/6 wild-type (apoM<sup>+/+</sup>) group (n = 24) and apoM gene-deficient (apoM<sup>−/−</sup>) group (n = 24) and then randomly subdivided into four subgroups (n = 6 each) according to different intraperitoneal (i.p.) injection: control group, W146 group, LPS group, and LPS + W146 group. Serum levels of interleukin-1 beta (IL-1β) and mRNA levels of IL-1β, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α), lung histology, wet/dry weight ratio, and immunohistochemistry were measured at 3 h after the baseline and compared in each group. Our results clearly demonstrated that IL-1β mRNA levels and other inflammatory biomarkers were significantly increased in the lungs of LPS-induced ALI apoM<sup>−/−</sup> mice compared to those of the apoM<sup>+/+</sup> mice. Moreover, when apoM<sup>+/+</sup> mice were treated with W146, a S1P receptor (S1PR1) antagonist, these inflammatory biomarkers could be significantly upregulated by LPS-induced ALI. Therefore, it suggests that apoM-S1P-S1PR1 signaling might underlie the pathogenesis of ALI and apoM could have physiological benefits to alleviate LPS-induced ALI.</p>}},
  author       = {{Zhu, Bin and Luo, Guang hua and Feng, Yue hua and Yu, Miao mei and Zhang, Jun and Wei, Jiang and Yang, Chun and Xu, Ning and Zhang, Xiao ying}},
  issn         = {{0360-3997}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{643--653}},
  publisher    = {{Springer}},
  series       = {{Inflammation}},
  title        = {{Apolipoprotein M Protects Against Lipopolysaccharide-Induced Acute Lung Injury via Sphingosine-1-Phosphate Signaling}},
  url          = {{http://dx.doi.org/10.1007/s10753-017-0719-x}},
  doi          = {{10.1007/s10753-017-0719-x}},
  volume       = {{41}},
  year         = {{2018}},
}